Researchers in Israel have experimented with Rapamycin treatment of cell cultures heteroplasmic for LHON G11778A.

They believe that the Rapamycin triggers the destruction of the mutation-carrying mitochondria, and the cells create new mitochondria without the G11778A mutation. ()http://www.ncbi.nlm.nih.gov/pubmed/24101601()


This page was last updated September 14 2015


Skip to toolbar